Centers for Disease Control and Prevention (CDC) — 2023 Investments
6 investments dated 2023 · listed companies and verified rows first · show all
Attogene is a biotechnology and biomanufacturing company that develops and manufactures rapid detection technologies, including lateral flow assays, ELISA kits, qPCR/qLAMP detection kits, and enzymatic assays for environmental monitoring and human disease analytes.
BiotechClimate TechMedical DevicesAustin, US
Eitr Bio develops single domain antibody-based immunotherapeutics through its Orthogonal Dual-Interacting Nanotherapeutic (ODIN) platform, including small bispecific molecules designed to penetrate solid tumors, gram-negative bacteria, and viral reservoirs in deep tissues.
BiotechDeep TechHealthtech
Mercato is an online grocery marketplace that lets shoppers order fresh food from locally-owned, independent grocers, butchers, and bakeries for delivery or in-store pickup.
E-commerceFoodTechMarketplacesNew York, US
Robert J. Brannigan, Jr.(Executive Officer, Director, Promoter)Bobby Brannigan(Founder)
Microgen Labs develops pathogen detection kits designed to identify viruses, bacteria, and fungi in various environments, with a focus on infections such as CMV, HSV, and syphilis.
BiotechHealthtechMedical Devices
Virongy develops and sells virology research products including pseudoviruses, transduction enhancers, protein expression vectors, viral concentration kits, and cell lines.
BiotechDeep TechHealthtech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.